U.S. pharma giant copyright scrapped two experimental weight loss capsules past year—a as soon as-every day pill, lotiglipron, resulting from elevated liver enzymes and a 2 times-each day capsule, danuglipron, as a consequence of powerful Unintended effects—but CEO Albert Bourla has mentioned the company is determined to “Engage in and acquir